Rezultati - Sohn, Joohyuk
- Showing 1 - 20 results of 39
- Go to Next Page
-
1
-
2
Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of... od Lee, Kyung-Hun, Sohn, Joohyuk, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Im, Seock-Ah, Kim, Sung-Bae
Izdano 2021Text -
3
-
4
-
5
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer od Hyun, Kyung-A, Koo, Gi-Bang, Han, Hyunju, Sohn, Joohyuk, Choi, Wonshik, Kim, Seung-Il, Jung, Hyo-Il, Kim, You-Sun
Izdano 2016Text -
6
Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis od Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon
Izdano 2020Text -
7
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs od Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Noguchi, Emi, Watanabe, Makiko, Sohn, Joohyuk, Lu, Yen‐Shen, Yap, Yoon‐Sim, Tamura, Kenji, Fujiwara, Yasuhiro
Izdano 2021Text -
8
-
9
A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide od Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk
Izdano 2019Text -
10
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups od Johnston, Stephen, O’Shaughnessy, Joyce, Martin, Miguel, Huober, Jens, Toi, Masakazu, Sohn, Joohyuk, André, Valérie A. M., Martin, Holly R., Hardebeck, Molly C., Goetz, Matthew P.
Izdano 2021Text -
11
Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR od Park, Hyung Seok, Han, Hyun Ju, Lee, Soohyeon, Kim, Gun Min, Park, Seho, Choi, Yeon A, Lee, Jeong Dong, Kim, Gi Moon, Sohn, Joohyuk, Kim, Seung Il
Izdano 2017Text -
12
Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy od Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Grischke, Eva‐Maria, Andre, Valerie, Stoffregen, Clemens, Shekarriz, Sarah, Price, Gregory L., Carter, Gebra Cuyun, Sledge, George W.
Izdano 2019Text -
13
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy od Kim, Chang Gon, Sohn, Joohyuk, Chon, Hongjae, Kim, Joo Hoon, Heo, Su Jin, Cho, Hyunsoo, Kim, In Jung, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Gun Min
Izdano 2016Text -
14
Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results od Park, Hyung Seok, Park, Seo-Jin, Kim, Jee Ye, Kim, Sanghwa, Ryu, Jaegyu, Sohn, Joohyuk, Park, Seho, Kim, Gun Min, Hwang, In Sik, Choi, Jong-Rak, Kim, Seung Il
Izdano 2017Text -
15
S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial od Moon, Yong Wha, Lee, Soohyeon, Park, Byeong-Woo, Kim, Eun-Kyung, Kim, Seung Il, Koo, Ja Seung, Park, Seho, Kim, Min Jung, Chung, Hyun Cheol, Kim, Joo-Hang, Sohn, Joohyuk
Izdano 2013Text -
16
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer od Ahn, Sung Gwe, Lee, Jae-Hoon, Lee, Hak Woo, Jeon, Tae Joo, Ryu, Young Hoon, Kim, Kun Min, Sohn, Joohyuk, Yun, Mijin, Lee, Seung Ah, Jeong, Joon, Kim, Seung Il
Izdano 2017Text -
17
Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication od Kim, Min Hwan, Lee, Soohyeon, Koo, Ja Seung, Jung, Kyung Hae, Park, In Hae, Jeong, Joon, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Park, Byeong-Woo, Kim, Joo-Hang, Sohn, Joohyuk
Izdano 2015Text -
18
Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy od Jung, Minkyu, Koo, Ja Seung, Moon, Young Wha, Park, Byeong-Woo, Kim, Seung Il, Park, Seho, Lee, Soo Hyun, Hong, Soojung, Rha, Sun Young, Chung, Hyun Cheol, Kim, Joo Hang, Sohn, Joohyuk
Izdano 2012Text -
19
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer od Bae, Soong June, Kim, Jee Hung, Ahn, Sung Gwe, Jeung, Hei-Cheul, Sohn, Joohyuk, Kim, Gun Min, Kim, Min Hwan, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Jeong, Joon
Izdano 2021Text -
20
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer od Chae, Young Kwang, Gagliato, Debora de Melo, Pai, Sachin Gopalkrishna, Carneiro, Benedito, Mohindra, Nisha, Giles, Francis Joseph, Ramakrishnan-Geethakumari, Praveen, Sohn, Joohyuk, Liu, Shuying, Chen, Huiqin, Ueno, Naoto, Hortobagyi, Gabriel, Gonzalez-Angulo, Ana Maria
Izdano 2016Text